| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Departure of James M. Mock
On August 15, 2022, James M. Mock, the Senior Vice President and Chief Financial Officer of PerkinElmer, Inc. (“PerkinElmer” or the “Company”), notified the Company that he is resigning as the Company’s Chief Financial Officer and terminating his employment effective as of September 5, 2022.
Appointment of Maxwell Krakowiak
On August 16, 2022, the Company’s Board of Directors (the “Board”) appointed Maxwell Krakowiak to serve as its Senior Vice President and Chief Financial Officer, effective as of September 6, 2022. He assumes the Chief Financial Officer role from James M. Mock, who has served as the Company’s Senior Vice President and Chief Financial Officer since 2018.
Mr. Krakowiak, age 33, joined the Company in October 2018 and has held a variety of financial leadership roles of increasing responsibility, most recently as the Company’s Vice President of Corporate Finance since October 2021, and before then as the Company’s Senior Director – Commercial Finance from November 2020 to October 2021, and prior to that as the Senior Director – Financial Planning & Analysis (FP&A) . Before joining the Company, Mr. Krakowiak served in several financial management roles at General Electric Company, a high-tech industrial company that operates worldwide with a focus on aviation, healthcare, renewable energy, and power, including Executive Manager – Corporate Audit Staff (“CAS”) from January 2018 to October 2018 and as Senior Manager – CAS from May 2014 to January 2018.
The Company will pay Mr. Krakowiak a starting annual base salary of $500,000 and he will be eligible to participate in the Company’s Global Incentive Compensation Plan with a target award opportunity of 75% of his annual salary. Mr. Krakowiak will also be able to participate in the Company’s annual Long-Term Incentive Program for 2023, receiving the following awards with an aggregate grant value equal to 225% of his base salary, divided as follows: 25% as a stock option subject to time-based vesting, 25% as restricted stock subject to time-based vesting and 50% as performance restricted stock units (“PRSUs”). The stock option will have an exercise price equal to the fair market value of PerkinElmer’s common stock on the date of grant and will cover the number of shares that results in a grant date fair value for the option equal to 25% of Mr. Krakowiak’s aggregate grant value under the program. Subject to Mr. Krakowiak’s continued service, the option will vest in three equal annual installments on the anniversary of the grant date, and will be exercisable for seven years from the date of grant. The number of restricted shares and PRSUs granted will be determined by dividing the applicable grant value by the closing price of PerkinElmer’s common stock on the date of grant. Subject to Mr. Krakowiak’s continued service, all of the restricted shares will vest on the third anniversary of the date of grant. The PRSUs will vest based on the achievement of financial performance goals at the end of a three-year performance period.
Mr. Krakowiak will also receive a sign-on equity grant equal to $500,000 in the aggregate, divided equally between stock options and restricted stock subject to time-based vesting. Subject to Mr. Krakowiak’s continued service, the stock option component will have an exercise price equal to the fair market value of PerkinElmer’s common stock on the date of grant, will vest in three equal installments on the anniversary of the grant date and will be exercisable for seven years from the grant date. The number of restricted shares granted will be determined by dividing the applicable grant value by the closing price of PerkinElmer’s common stock on the date of grant. Subject to Mr. Krakowiak’s continued service, all of the restricted shares will vest on the third anniversary of the date of grant.
In connection with his new position, Mr. Krakowiak and the Company entered into a new employment agreement dated August 16, 2022 (the “Agreement”). The Agreement has an initial term of one year, continues until terminated and is similar to employment agreements the Company has with other executive officers. The Agreement includes non-competition and non-solicitation covenants by Mr. Krakowiak running through one year following the end of his employment, as well as severance and change of control provisions. In the event Mr. Krakowiak’s employment is terminated by the Company without “cause”, as that term is defined in the Agreement, Mr. Krakowiak would be entitled to receive his “full salary” for a period of one year following his termination and a lump sum payment equal in value to the amount that the Company would have paid in premiums for his benefit plans and arrangements for a
